OTL-101 granted Rare Pediatric Disease designation – The Pharma Letter (registration)
|
OTL-101 granted Rare Pediatric Disease designation
The Pharma Letter (registration) The US Food and Drug Administration has granted a Rare Pediatric Disease designation to OTL-101, for the treatment of adenosine deaminase severe … |
